Product Information
HALOPERIDOL 5 MG TABLET is a generic product labeled by Mylan Institutional LLC, priced at $0.1807 per EA under NDC 51079073620. Its NADAC has been published 668 times since Nov 28, 2013.
FDA first approved this application on Jun 10, 1986. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Mylan Institutional LLCNDC
51079073620
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HALOPERIDOLApproval Type
Generic (ANDA)
FDA Application
ANDA070278FDA Approved
6/10/1986
TE Code
AB
On Market Since
2/15/2004
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL 5 MG TABLET has been published 668 times since Nov 28, 2013, and over the history we have for it it has declined 52.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1807 per EA |
|---|---|
| All-time high | $0.7992 (Aug 13, 2014) |
| All-time low | $0.1752 (Jun 17, 2026) |
| 52-week high | $0.1980 |
| 52-week low | $0.1752 |
| Median price | $0.4443 |
| Average price | $0.4491 |
| Largest weekly change | +56.9% (Mar 19, 2014) |
| Weeks tracked | 668 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Institutional LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
haloperidol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL 5 MG TABLET, manufactured by Mylan Institutional LLC, is $0.1807 per EA (NDC 51079073620), effective Sep 30, 2026.
How has the price of HALOPERIDOL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL 5 MG TABLET has declined 52.0%. It has been tracked across 668 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL 5 MG TABLET?
Since Nov 28, 2013, the NADAC for HALOPERIDOL 5 MG TABLET has ranged from a low of $0.1752 (Jun 17, 2026) to a high of $0.7992 (Aug 13, 2014), with a median of $0.4443 per EA.
Are there cheaper alternatives to HALOPERIDOL 5 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HALOPERIDOL 5 MG TABLET, is $0.1782 per EA — about 1% below HALOPERIDOL 5 MG TABLET.
Who manufactures HALOPERIDOL 5 MG TABLET?
HALOPERIDOL 5 MG TABLET (NDC 51079073620) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.